Search for: "H. LUNDBECK A/S"
Results 21 - 40
of 55
Sort by Relevance
|
Sort by Date
21 Jul 2014, 10:32 am
For example, as was stated in Generics (UK) Limited and others v H Lundbeck A/S [2009] UKHL 12: “National courts may reach different conclusions as to the evaluation of the evidence in the light of the relevant principles, but the principles themselves should be the same, stemming as they do from the EPC. [read post]
27 Apr 2014, 4:16 am
And, it seems, rightly so – because on 11 April 2014 the High Court of Australia granted ‘special leave’ (transcript at Alphapharm Pty Ltd v H Lundbeck A/S & Ors [2014] HCATrans 79), allowing generic manufacturer Alphapharm Pty Ltd to appeal the Federal Court decision.In fact, Alphapharm was only 50% successful in its bid. [read post]
25 Nov 2013, 7:10 am
This has now been issued as Resolution Chemicals Ltd v H Lundbeck A/S [2013] EWCA Civ 1515 (25 November 2013), which is available on BAILII here.Now this Kat needs to explain his own particular interest in the story. [read post]
24 Oct 2013, 12:49 pm
” Merpel had just read the latest judgment of Mr Justice Arnold in the Patents Court, England and Wales, in Resolution Chemicals Limited v H Lundbeck A/S [2013] EWHC 3160 (Pat). [read post]
30 Jul 2013, 3:23 pm
Lundbeck A/S [2013] EWCA Civ 924. [read post]
18 Apr 2013, 3:37 am
Lundbeck A/S [2013] EWHC 739 (Pat) (12 April 2013)] from last week of Mr Justice Arnold on everyone’s favourite niche IP blog, THE SPC BLOG. [read post]
31 Dec 2011, 1:00 pm
The deal fell apart a little more than a month after the Antitrust Division was handed an important victory when the federal district court in Washington, D.C. enjoined the proposed acquisition by H&R Block Inc. of TaxACT, a digital do-it-yourself tax-preparation software provider, at the government’s request (2011-2 Trade Cases ¶77,678). [read post]
5 Jul 2011, 1:44 pm
He noted that:[457] “…the Opposition Division rejected the allegation that 877 was obvious over Professor Smith’s talk at the Banbury Conference. [read post]
15 Jun 2011, 4:56 am
Lundbeck A/S (IP Whiteboard) (Patentology) Focalin XR (Dexmethylphenidate) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. et al. v. [read post]
15 Apr 2011, 4:09 am
Court of Appeal (Civil Division) Cardinal Vaughan Memorial School, R (on the application of) v The Archbishop of Westminster & Anor [2011] EWCA Civ 433 (14 April 2011) H and L v A City Council [2011] EWCA Civ 403 (14 April 2011) Marcroft v Heartland (Midlands) Ltd [2011] EWCA Civ 438 (14 April 2011) Desai v National Car Parks Services (NCP) [2011] EWCA Civ 402 (14 April 2011) Court of Appeal (Criminal Division) Deeney, R. v [2011] EWCA Crim 893 (14 April 2011) R & Anor, R. v [2011]… [read post]
15 Mar 2011, 9:22 pm
"It's against everything we stand for," said Mads Kronborg, a spokesman for H. [read post]
22 Jul 2010, 8:35 am
Pharma IQ’s BioPatent Design offers you the perfect gathering to find your solutions. [read post]
14 Jul 2010, 6:47 pm
Glaxo tries a ‘Linux’ (Spicy IP) TB Alliance and DNDi team up to fight neglected diseases (IP Watch) Australia: Pharmaceuticals extensions and international inequities: H Lundbeck A/S v Alphapharm Pty Ltd, Ortho-McNeil Pharmaceutical, Inc v Lupin Pharmaceuticals, Inc (Patentology) Australia: The ‘morality’ of gene patents (Patentology) Belgium: Antwerp commercial court finds Belgian counterpart of EU patent covering process for producing L-Lysine by… [read post]
13 May 2010, 4:58 pm
Lundbeck A/S v. [read post]
22 Jul 2009, 6:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 Jul 2009, 7:14 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Jun 2009, 10:17 am
The decision, H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70, involves a decision of the Full Federal Court on rehearing an appeal by Alphapharm over an earlier decision regarding Lundbeck's Australian Patent No. 623144 for the antidepressant drug escitalopram. [read post]
17 Jun 2009, 3:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Jun 2009, 3:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
